Avg closing price
Price range

22 Ray Dalio United Therapeutics Trades

Ray Dalio acquired 9.02 Thousand United Therapeutics shares worth $2.19 Million. That's 0.01% of their equity portfolio (500th largest holding). The first United Therapeutics trade was made in Q4 2015. Since then Ray Dalio bought shares eleven more times and sold shares on ten occasions. The stake costed the investor $1.92 Million, netting the investor a gain of 14% so far.

Avg closing price
Price range
Sold 50.3% shares (-9.13 Thousand shares) Q4 2023
Avg closing price $230.49
Price range $214.88 - $256.94
Sold 55.5% shares (-22.7 Thousand shares) Q3 2023
Avg closing price $230.33
Price range $211.82 - $248.24
Sold 1.1% shares (-460 shares) Q2 2023
Avg closing price $221.50
Price range $205.19 - $232.99
Increased shares by 64.4% (+16.2 Thousand shares) Q1 2023
Avg closing price $246.53
Price range $212.99 - $276.17
Sold 43.2% shares (-19.1 Thousand shares) Q4 2022
Avg closing price $252.44
Price range $205.95 - $280.43
Sold 18.8% shares (-10.2 Thousand shares) Q3 2022
Avg closing price $223.56
Price range $203.30 - $244.17
New holding (+54.4 Thousand shares) Q2 2022
Avg closing price $203.30
Price range $174.81 - $241.14
Sold -9.12 Thousand shares Q2 2019
Avg closing price $93.51
Price range $76.06 - $120.81
New holding (+9.12 Thousand shares) Q1 2019
Avg closing price $116.52
Price range $107.15 - $126.84
Sold -53.7 Thousand shares Q4 2018
Avg closing price $115.95
Price range $101.40 - $128.73
Increased shares by 18.5% (+8.4 Thousand shares) Q3 2018
Avg closing price $123.69
Price range $113.81 - $129.46
Sold 71.9% shares (-116 Thousand shares) Q2 2018
Avg closing price $109.92
Price range $101.14 - $118.31
Increased shares by 72.2% (+67.6 Thousand shares) Q1 2018
Avg closing price $127.04
Price range $107.21 - $151.94
Increased shares by 1.0% (+953 shares) Q4 2017
Avg closing price $127.12
Price range $118.58 - $151.28
Increased shares by 25.4% (+18.8 Thousand shares) Q3 2017
Avg closing price $127.70
Price range $114.60 - $136.81
Increased shares by 27.3% (+15.9 Thousand shares) Q2 2017
Avg closing price $124.75
Price range $118.34 - $133.12
Increased shares by 32.3% (+14.2 Thousand shares) Q1 2017
Avg closing price $151.49
Price range $135.38 - $168.42
Sold 61.4% shares (-69.9 Thousand shares) Q4 2016
Avg closing price $127.68
Price range $111.68 - $145.38
Increased shares by 77.5% (+49.7 Thousand shares) Q3 2016
Avg closing price $120.15
Price range $107.73 - $129.64
Sold 25.3% shares (-21.7 Thousand shares) Q2 2016
Avg closing price $111.55
Price range $98.33 - $121.03

News about United Therapeutics Corp and Ray Dalio

Embed chart

Easily embed the chart on your blog or website – it will always update automatically!